Find Icosabutate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1253909-57-7, Icosabutate [inn], Icosabutate [who-dd], Prc-4016, Nst-4016, Prb-01022
Molecular Formula
C24H38O3
Molecular Weight
374.6  g/mol
InChI Key
VOGXDRFFBBLZBT-AAQCHOMXSA-N
FDA UNII
562599X5JL

Icosabutate
Icosabutate is under investigation in clinical trial NCT02373176 ([14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study).
1 2D Structure

Icosabutate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]butanoic acid
2.1.2 InChI
InChI=1S/C24H38O3/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-27-23(4-2)24(25)26/h5-6,8-9,11-12,14-15,17-18,23H,3-4,7,10,13,16,19-22H2,1-2H3,(H,25,26)/b6-5-,9-8-,12-11-,15-14-,18-17-
2.1.3 InChI Key
VOGXDRFFBBLZBT-AAQCHOMXSA-N
2.1.4 Canonical SMILES
CCC=CCC=CCC=CCC=CCC=CCCCCOC(CC)C(=O)O
2.1.5 Isomeric SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCOC(CC)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
562599X5JL
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1253909-57-7

2. Icosabutate [inn]

3. Icosabutate [who-dd]

4. Prc-4016

5. Nst-4016

6. Prb-01022

7. 562599x5jl

8. 2-[(5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenoxy]butanoic Acid

9. Butanoic Acid, 2-((5z,8z,11z,14z,17z)-5,8,11,14,17-eicosapentaen-1-yloxy)-

10. Rac-2-((5z,8z,11z,14z,17z)icosa-5,8,11,14,17-pentaen-1-yloxy)butanoic Acid

11. 2-[(5z,8z,11z,14z,17z)-5,8,11,14,17-eicosapentaen-1-yloxy]-butanoicacid

12. Icosabutate [usan:inn]

13. Unii-562599x5jl

14. Icosabutate (usan/inn)

15. Icosabutate [usan]

16. Schembl289973

17. Chembl3707220

18. Db12990

19. Hy-121212

20. Cs-0081238

21. D11211

22. Q27261360

23. 2-((5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanoic Acid

24. 2-((5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenyloxy)butanoic Acid

2.4 Create Date
2014-09-29
3 Chemical and Physical Properties
Molecular Weight 374.6 g/mol
Molecular Formula C24H38O3
XLogP36.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count17
Exact Mass374.28209507 g/mol
Monoisotopic Mass374.28209507 g/mol
Topological Polar Surface Area46.5 Ų
Heavy Atom Count27
Formal Charge0
Complexity484
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count5
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of non-alcoholic fatty liver disease including non-alcoholic steatohepatitis


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty